SCHEMBL7435602

SCHEMBL7435602

COc1ccc(C(=O)C(N)C(C)=O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 6/20 0.55
CA2 P00918 6/20 0.55
PARP10 Q53GL7 2/20 0.55
PARP1 P09874 1/20 0.55
PARP2 Q9UGN5 1/20 0.55
PARP4 Q9UKK3 1/20 0.55
CES2 O00748 2/20 0.53
CES1 P23141 2/20 0.53
ALDH1A1 P00352 1/20 0.53
CYP1A2 P05177 1/20 0.53
MAPT P10636 2/20 0.50
HDAC3 O15379 1/20 0.50
HDAC4 P56524 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC10 Q969S8 1/20 0.50
HDAC11 Q96DB2 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28222504 0.85 ALDH1A1 (0.62) CA1CA2PARP10PARP1PARP2
SCHEMBL19763136 0.84 CA1 (0.53) CA1CA2PARP10PARP1PARP2
Hydrochloric Acid SCHEMBL28222455 0.84 ALDH1A1 (0.60) CA1CA2PARP10PARP1PARP2
SCHEMBL9369669 0.81 CA1 (0.59) CA1CA2PARP10PARP1PARP2
SCHEMBL9040102 0.81 CA1 (0.59) CA1CA2PARP10PARP1PARP2
SCHEMBL15520071 0.81 CA1 (0.59) CA1CA2PARP10PARP1PARP2
SCHEMBL5217024 0.80 CES2 (0.61) CA1CA2PARP10PARP1PARP2
Hydrochloric Acid SCHEMBL6704589 0.79 CA1 (0.57) CA1CA2PARP10PARP1PARP2
Hydrochloric Acid SCHEMBL1309644 0.78 CA1 (0.52) CA1CA2PARP10PARP1PARP2
SCHEMBL6653842 0.76 CA1 (0.53) CA1CA2PARP10PARP1PARP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4999365-A Preventing damage which occurs to heart tissue when oxygen is reintroduced after a heart attack MERRELL DOW PHARMACEUTICALS INC. (US) 1991-03-12 US disclosed
EP-0284925-A2 Use of imidazol-2-thiones for the preparation of a medicament for reducing myocardial stunning MERRELL DOW PHARMACEUTICALS INC. (US) 1988-10-05 EP disclosed
US-4405628-A 4-Pyridylimidazolones and method of use MERRELL DOW PHARMACEUTICALS INC. (US) 1983-09-20 US disclosed
EP-0059948-A1 Novel aroylimidazolones MERRELL DOW PHARMACEUTICALS INC. (US) 1982-09-15 EP disclosed